Schedule 13G ownership disclosure
EastBridge Investment Group Corp
Security class unavailable · CUSIP: 276050101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 710,452
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-18-000310
- Form type
- SC 13G
- Filer
- Cellular Biomedicine Group, Inc.
- CIK
- CIK 1378624
- Filed
- Mar 01, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership